Related Experiment Video
Updated: Jun 26, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Voriconazole use for endemic fungal infections
Alison Freifeld1, Laurie Proia, David Andes
1University of Nebraska Medical Center, Omaha, Nebraska, USA. afreifeld@unmc.edu
Abstract:
In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8%) within 2 months of starting voriconazole and for 20 (83.3%) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.
Related Concept Videos
Antifungal Agents
Candidiasis
Cryptococcal Meningitis
Antiprotozoal Agents
Anthelminthic Agents
Endocarditis III: Medical Management
